CSL International Revenue and Competitors
Estimated Revenue & Valuation
- CSL International's estimated annual revenue is currently $52M per year.
- CSL International's estimated revenue per employee is $360,800
Employee Data
- CSL International has 144 Employees.
- CSL International grew their employee count by -9% last year.
CSL International's People
Name | Title | Email/Phone |
---|
CSL International Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $68.6M | 190 | 24% | N/A | N/A |
#2 | $69.3M | 192 | 14% | N/A | N/A |
#3 | $52.7M | 146 | 3% | N/A | N/A |
#4 | $84.4M | 234 | 20% | N/A | N/A |
#5 | $0.2M | 5 | -83% | $22.7M | N/A |
#6 | $421.1M | 917 | 20% | N/A | N/A |
#7 | $44.3M | 135 | 22% | N/A | N/A |
#8 | $53.4M | 148 | 4% | N/A | N/A |
#9 | $37.4M | 114 | 15% | N/A | N/A |
#10 | $70M | 194 | 0% | N/A | N/A |
What Is CSL International?
Learn about working at CSL International. Join LinkedIn today for free. See who you know at CSL International, leverage your professional network, and get hired.
keywords:N/AN/A
Total Funding
144
Number of Employees
$52M
Revenue (est)
-9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
CSL International News
2022-04-19 - Fibrinogen Concentrates Market Size, Scope And Forecast ...
CSL Behring, Baxter International Inc., LFB Group, ProFibrix BV, Shanghai RAAS, Jiangxi Boya Bio-Pharmaceutical, Hualan Biological Engineering,...
2022-04-17 - CSL launches Dualcom Pro 2 variants
CSL has launched its latest variants to its EN54-certified fire range ... or visit CSL's stand (IF3820) at IFSEC International to speak to a...
2022-03-30 - Nashville's fairgrounds racetrack renovation in holding pattern
Cooper's administration said last year that if the report from consultant CSL International now known as CSL Americas "confirms the...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $22.2M | 144 | N/A | N/A |
#2 | $40.2M | 144 | 13% | N/A |
#3 | $42.8M | 144 | 29% | N/A |
#4 | $38.8M | 144 | 3% | N/A |
#5 | $40.1M | 144 | 6% | N/A |